复杂心脏手术围术期静脉补铁对输血需求的影响:随机双盲安慰剂对照试验
主要终点为术后10天内pRBC输血比例,两组分别为60.4%和57.2%(P=0.651),无显著差异;但铁剂组术后3周血红蛋白更高,网织红细胞计数增加,铁储备改善。
要点
- 复杂心脏手术围术期静脉补铁未减少pRBC输血比例。
- 铁剂组术后3周血红蛋白和网织红细胞计数显著高于对照组。
- 铁剂组铁调素水平升高,可能削弱补铁促红细胞生成效应。
核心结论
- 复杂心脏手术住院期间静脉补铁虽补充铁储备并增强红细胞生成,但未减少pRBC输血,可能与铁调素表达增强有关。
研究设计与样本
- 围术期两次给药:术前3天和术后,铁剂组给予 ferric derisomaltose 20 mg/kg,对照组给予安慰剂。
主要发现
- 主要终点pRBC输血比例:对照组60.4%,铁剂组57.2%(P=0.651)。
- 术后3周血红蛋白:铁剂组11.6±1.5 g/dL,对照组10.9±1.4 g/dL(P<0.001)。
- 术后第10天网织红细胞计数:铁剂组205(150-267)×10^3/μL,对照组164(122-207)×10^3/μL(P=0.003)。
- 术后第3天铁调素:铁剂组106.3(42.9-115.9)ng/mL,对照组39.3(33.3-43.6)ng/mL(P<0.001)。
- 转铁蛋白饱和度和血清铁蛋白铁剂组显著高于对照组(P<0.001);促红细胞生成素两组术后均升高(P=0.003),组间无差异。
临床怎么用
- 复杂心脏手术围术期常规静脉补铁不应以减少输血为主要目的。
- 补铁可改善术后血红蛋白和铁储备,但需权衡铁调素升高对红细胞生成的潜在抑制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We investigated whether routine perioperative intravenous iron replenishment reduces the requirement for packed erythrocytes (pRBC) transfusion. SUMMARY OF BACKGROUND DATA: Patients undergoing complex cardiac surgery are at high risk of developing postoperative iron deficiency anemia, thus requiring transfusion, which is associated with adverse outcomes. METHODS: Patients were randomized to receive either ferric derisomaltose 20 mg/kg (n = 103) or placebo (n = 101) twice during the perioperative period: 3 days before and after the surgery. The primary endpoint was the proportion of patients who received pRBC transfusion until postoperative day (POD) 10. Hemoglobin, reticulocyte count, serum iron profile, hepcidin, and erythropoietin were serially measured. RESULTS: pRBC was transfused in 60.4% and 57.2% of patients in the control and iron group, respectively (P = 0.651). Hemoglobin concentration at 3 weeks postoperatively was higher in the iron group than in the control group (11.6 ± 1.5 g/dL vs 10.9 ± 1.4 g/dL, P < 0.001). The iron group showed higher reticulocyte count [205 (150-267)×103/μL vs 164 (122-207)×103/μL, P = 0.003] at POD 10. Transferrin saturation and serum ferritin were significantly increased in the iron group than in the control group (P < 0.001). Serum hepcidin was higher in the iron group than in the control group at POD 3 [106.3 (42.9-115.9) ng/mL vs 39.3 (33.3-43.6) ng/mL, P < 0.001]. Erythropoietin concentration increased postoperatively in both groups (P = 0.003), with no between-group difference. CONCLUSIONS: Intravenous iron supplementation during index hospitalization for complex cardiac surgery did not minimize pRBC transfusion despite replenished iron store and augmented erythropoiesis, which may be attributed to enhanced hepcidin expression.
引用
- Song JW, Soh S, Shim JK, et al. Effect of Perioperative Intravenous Iron Supplementation for Complex Cardiac Surgery on Transfusion Requirements: A Randomized, Double-blinded Placebo-controlled Trial. Ann Surg. 2022. PMID: 34171864. doi:10.1097/SLA.0000000000005011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。